期刊文献+

野生型p53基因对胰腺癌细胞的抑制作用 被引量:1

Effect of human wild-type p53 gene expression on the biological behavior of Human pancreatic cancer cell line
下载PDF
导出
摘要 目的 观察人类野生型p5 3 (wtp5 3 )基因对人胰腺癌细胞系的抑制作用。方法 用逆转录病毒为载体将外源性wtp5 3基因导入人胰腺癌细胞系PC -2 ,通过体外及小鼠体内实验研究转入基因的表达及对肿瘤的抑制作用。结果 p5 3在转染细胞PC -2 /p5 3中表达水平提高。外源性wtp5 3基因的导入和表达能使PC -2细胞的生长速率减低 ,软琼脂集落形成能力下降 ,G0 +G1期细胞比例增加 ,凋亡指数升高 ,裸鼠体内成瘤能力明显下降。结论 逆转录病毒载体介导的外源性野生型p5 Objective To observe the inhibitory effects of human wild-type p53(wtp53) gene on human pancreatic cancer cell line. Methods Retroviral vector was used to introduce exogenous wtp53 gene into human pancreatic cancer cell line PC-2, Gene expression and tumor inhibition were studied in vitro and in vivo . Results The expression of p53 in transfected cell lines(PC-2/p53) increased. The introduction and expression of exogenous wtp53 gene resulted in decreased growth rate and reduced ability to form colony in soft agar in PC-2 cells. The G 0+G 1 ratio increased and S ratio decreased in cell cycle distribution, and apoptosis index significantly increased in PC-2/p53 cells. The tumorigenicity of PC-2/p53 cells in nude mice was significantly suppressed by exogenous p53. Conclusion Exogenous wtp53 mediated by retroviral vector can inhibit the growth of human pancreatic cancer cell.
出处 《广东医学》 CAS CSCD 2002年第11期1141-1143,共3页 Guangdong Medical Journal
关键词 野生型P53基因 胰腺癌 抑制作用 基因疗法 Pancreatic neoplasms Genes p53 Gene therapy Retrovirus
  • 相关文献

参考文献1

二级参考文献2

  • 1樊代明,解放军医学杂志,1988年,13卷,12页
  • 2樊代明,中华消化杂志,1988年,8卷,5期,35页

共引文献3

同被引文献14

  • 1Ariyama C,Lundin J,Kunsela P, et al.CA242,a new tumor marker for pan-creatic cancer, a comparison with CA199, CA50 and CEA[J].Br J Cancer, 1994,70(3):487.
  • 2Motti ML,Califano D,Troncone G,et al.Viglieto G Complex regulation of the cyclin-dependent kinase inhibitor P27 kipl in thyroid cancer cells by the PI3K/AKT pathway:regulation of P27 kiple xpressiona ndl ocalization[J].A mJ P athol,2005,166(5):737.
  • 3Kawa JT, Wu CP, Deng HF et al.Serum level of TSGF, CA242 and CA199 in pancreatic cancer[J].World J Gastroenterol,2004,10(1 1): 1675.
  • 4Lundin J,Roberts PJ,Kuusela P, et al.Prognosticsig-nificance of serum CA242 in pancreatic cancer Acom-parison with CA199[J]. Anticancer Res, 1995,15(11 ):2181.
  • 5Koopmannet S,Tomoo M,Hasebe O,et al.Com-parative study of CA242 and CA199 for the diagnosis of pancreatic cancer[J].Br J Cancer, 1994,70(3):481.
  • 6Tahara AR,Brown DA,Kuffner T,et al.Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosiso fca ncer[J]. Cancer Res,2006,66(22):4983.
  • 7Yamaguch H,Filipovic Z,Brown D,et al.Macrophagei nhibitoryc ytokine-l:a novel biomarker for P53 pathway activation[J].Mol Cancer Ther,2003,2(7): 1023.
  • 8Warren Miranda,Jin X,Hsiao EC,et al.Growth differentiationfactor-15:in ductioninli verin juryth rough P53 and tumor necrosisf actor-independentm echanisms[J].J Surg Res,2006,130(1):45.
  • 9Koopmann J,Rosenzweig CN,Zhang Z,et al.Serum markers in patients with resectablep ancreaitca denocarcinoma:maerophage inhibitory cytokine lversus CA199[J].Cl in Cancer Res,2006,12(2):441.
  • 10Liu T, Bauskin AR,Zaunders J,et al.Macrophage inhibitorycytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells[J].Cancer Res,2003,63(28):5034.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部